Mycoplasma Pneumoniae Infections - Related Resources

Cochrane reviews

There is insufficient evidence from trials about the benefits of antibiotic treatment for lower respiratory tract infections in children secondary to Mycoplasma pneumoniae Antibiotics for Lower Respiratory Tract Infections Secondary to M. Pneumoniae in Children.

Ragnar Norrby S. Atypical pneumonia in the Nordic countries: aetiology and clinical results of a trial comparing fleroxacin and doxycycline. Nordic Atypical Pneumonia Study Group. J Antimicrob Chemother 1997 Apr;39(4):499-508. [PubMed] J Antimicr Chemother 1997;39:499-508
Korppi M, Heiskanen-Kosma T, Kleemola M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 2004 Mar;9(1):109-14. [PubMed]
Gavranich JB, Chang AB. Antibiotics for community acquired lower respiratory tract infections (LRTI) secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev 2005 Jul 20;(3):CD004875. [PubMed]
Lode HM. Managing community-acquired pneumonia: a European perspective. Respir Med 2007 Sep;101(9):1864-73. [PubMed]
Bartlett JG. Is activity against "atypical" pathogens necessary in the treatment protocols for community-acquired pneumonia? Issues with combination therapy. Clin Infect Dis 2008 Dec 1;47 Suppl 3():S232-6. [PubMed]

Primary/Secondary Keywords